Form 4/A for CERS CERUS CORP
Accepted 2023-01-03 00:00:00 ET · period of report 2022-12-28 · accession 0001209191-23-000425 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2023-01-03 | 2022-12-28 | CERS | SCHULZE GAIL | Dir | M - OptEx | $3.19 | +25.0K | 73.6K | +51% | +$79.8K |
| DA | 2023-01-03 | 2022-12-28 | CERS | SCHULZE GAIL | Dir | M - OptEx | — | -25.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-28 | M | A | 25,000 | $3.19 | 73,570 | D | — | — | |
| 2 | Derivative | Option (Right to Buy) | 2022-12-28 | M | D | 25,000 | — | 0 | D | $3.19 · — to 2023-01-01 | 25,000 Common Stock | (F2) Not applicable. (F1) The option became exercisable in 12 equal monthly installments after the grant date. |